⌘K

Login Start Free

Home/Filings/4/0000950170-25-093852

4//SEC Filing

Clark Eliana 4

Accession 0000950170-25-093852

CIK 0001652130other

View on SEC.gov Company Profile

Filed

Jul 2, 8:00 PM ET

Accepted

Jul 3, 4:11 PM ET

Size

4.7 KB

Accession

0000950170-25-093852

Insider Transaction Report

Form 4

Period: 2025-07-01

Intellia Therapeutics, Inc.NTLA

EVP, Chief Technical Officer

Transactions

Sale
Common Stock
2025-07-01$9.82/sh−1,022$10,036→ 95,369 total

Footnotes (1)

[F1]Sale of 1,022 shares that were acquired under the Intellia Therapeutics, Inc. 2016 Employee Stock Purchase Plan on June 30, 2025.

Documents

1 file

4
ownership.xmlPrimary
4

Issuer

Intellia Therapeutics, Inc.

CIK 0001652130

Entity typeother

Related Parties

1

filerCIK 0001914448

Filing Metadata

Form type: 4
Filed: Jul 2, 8:00 PM ET
Accepted: Jul 3, 4:11 PM ET
Size: 4.7 KB

View on SEC.gov